USPTO 2015–2025 USPTO PatentsView Foreign Corporation

LTS Lohmann Therapie-Systeme AG

USPTO PatentsView assignee record — 149 granted patents across 37 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

149
Total patents granted
37
CPC technology areas
16.7
Avg claims per patent
+26%
5-year filing velocity

The verdict

LTS holds 149 US patents across 37 technology areas — rank #2,610 of 50,000 tracked assignees.

#2,610
of 50,000 US assignees by volume
Top 5%
by Innovation Score (58.0/100)
16.7
avg claims per patent
+26%
filing velocity, last 5 yrs

Portfolio overview

LTS Lohmann Therapie-Systeme AG has been granted 149 US utility patents between 2015 and 2025, placing LTS Lohmann Therapie-Systeme AG at rank #2,610 across all assignees tracked by PlainPatent. This portfolio spans 37 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, LTS Lohmann Therapie-Systeme AG is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 58.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 83 grants, compared with 66 in the 2015–2019 window — a +26% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. LTS Lohmann Therapie-Systeme AG's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 37 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark LTS Lohmann Therapie-Systeme AG against peers pursuing similar technology classes.

How does LTS compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows LTS holds 149 patents — placing it at rank #2,610 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

LTS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

510152025 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
LTS Lohmann Therapie-Systeme AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 20 13.4%
2016 14 9.4%
2017 12 8.1%
2018 9 6.0%
2019 11 7.4%
2020 11 7.4%
2021 12 8.1%
2022 19 12.8%
2023 14 9.4%
2024 14 9.4%
2025 13 8.7%

Which technologies does LTS Lohmann Therapie-Systeme AG patent most?

Top 15 of 37 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#2,610

Across all tracked assignees

Innovation Score

58.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does LTS Lohmann Therapie-Systeme AG hold?
LTS Lohmann Therapie-Systeme AG holds 149 US granted patents filed between 2015 and 2025, spanning 37 technology areas.
What is LTS Lohmann Therapie-Systeme AG's Innovation Score?
LTS Lohmann Therapie-Systeme AG has an Innovation Score of 58.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does LTS Lohmann Therapie-Systeme AG focus on?
LTS Lohmann Therapie-Systeme AG's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 112 patents. The company has filed patents in 37 CPC subclasses total.
Is LTS Lohmann Therapie-Systeme AG's patent filing rate increasing or decreasing?
LTS Lohmann Therapie-Systeme AG's recent filing velocity is +26% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for LTS Lohmann Therapie-Systeme AG's patents?
LTS Lohmann Therapie-Systeme AG's patents average 16.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the LTS Lohmann Therapie-Systeme AG patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope